Download PDF  |  Print  |  Close Window
  The Medicine and Surgery (1982): September Issue
Bonnisan in gastrointestinal disturbances in infants and young children

Tripti Sethi, S. Saxena and P.P. Gupta, Department of Pediatric Medicine, Sir Padampat Mother and Child Health Institute, Jaipur, India.
 
 
 Introduction

Gastrointestinal disorders are one of the commonest problems, of great concern to the parents and doctors caring for infants and young children. Although a large group of these disorders comprise various infections and infestations of the gastrointestinal tract, an equal number of problems are due to the so-called minor gastrointestinal upsets which occur frequently and are a matter of grave concern in neonates and infants, as their exact etiopathogenesis is not clear. A child is born with an anatomically perfect gastrointestinal system, but physiological maturity is acquired gradually, in months and perhaps years after birth, as individual variations are always there. This physiological immaturity coupled with poor intestinal motility and immaturity of liver functions gives rise to intestinal upsets which reflect in poor growth and development of the child. Due to these frequently occurring gastrointestinal problems, parents and doctors get confused and keep changing milk, or use antispasmodics and various enzymes which do not really work. As a result, the child gradually begins to lose weight.

A formula which is simple, palatable and would relieve gases, colics and at the same time stimulate digestion, absorption and stimulate liver enzymes, would be an ideal remedy for these problems. Bonnisan has been promoted as such a remedy. It has been studied by various workers and is proved as an appetite stimulant, growth promoter1 and a very good carminative. This view has been thoroughly investigated from various angles by a number of workers3-5. Bonnisan contains Dill oil, ingredients of Liv.52, extracts of Tinospora cordifolia, Piper longum,Emblica officinalis, Elettaria cardamomum, Tribulus terrestris and Boerhaavia diffusa processed in the fresh juices and decoctions of various digestive and hepatic stimulants.


 Material and Methods

This study was conducted at Sir Padampat Mother and Child Health Institute, Jaipur. One hundred and fifty newborns and infants up to 3 years of age, suffering from gastrointestinal problems of various types and not receiving any other medication, were taken up for the purpose of this study.


Table I: Dosage schedule

Sl. No.

Age group in months

Bonnisan in t.s.f.

Frequency/day

1.

0 - 1

¼ - ½

3 - 4

2.

1 - 6

½ - 1

3 - 4

3.

6 - 12

1 - 2

3 - 4

4.

12 - 24

2 - 3

3 - 4

5.

24 - 36

3 - 4

3 - 4


There were 70 males and 80 females. Ninety were below the age of one year (Table II)

Table II : Age and sex distribution of the cases

   

Age Groups in Months

Total cases  

0-5

6-12

13-18

19-24

25-36

Females

70

30

10

10

10

10

Males

80

40

10

10

10

10

A detailed history of complaints and other relevant information regarding their previous growth and development were recorded on a planned proforma. Bonnisan was started on these patients according to dosage in Table I. These cases were followed up in the outdoor clinics at first, weekly for one month, and then twice a month for six to eight months. On every visit the relief of symptoms were enquired into and confirmed with detailed examination. A weight record was kept as an index of improvement.

The mothers were instructed to bring their children to the hospital immediately, if they observed any increase in or appearance of new problems, before resorting to any home-remedies or consulting their family doctor. Ten cases which did not conform strictly to the protocol were not included in the study.

"Vague illness" as in Table III is noted in those patients who have nothing positive on examination but the parents complain that the child is not playful like the others and he is either irritable or dull. Another common problem for the parents, taken up here are teething problems -which usually includes irritability, excessive salivation, swollen gums and mild diarrhoea, at the time of eruption of teeth.

Table III : Results of therapy in various symptom groups

Symptom Groups

No. of cases

Percentage to Total

Number of cases showing definite improvement

Percentage
improvement

Failure to gain weight

20

13.3

15

75.0

Anorexia

30

20.0

20

66.6

Colics

30

20.0

26

86.6

Vomiting / Regurgitation

15

10.0

10

66.6

Mild Diarrhoea/non-specific

5

3.3

3

60.0

Constipation

15

10.0

14

93.3

Abdominal distension

10

6.6

8

80.0

Vague illness

10

6.6

7

70.0

Post-antibiotic dyspespsia

5

3.3

5

100.0

Teething problems

10

6.6

8

80.0

Total

150

-

116

77.3


 Results

Out of hundred and fifty cases, 70 were females and 80 were males. The distribution of cases age-wise is shown in Table II.

As is evident from Table III, 116 cases with gastrointestinal problems improved significantly with Bonnisan therapy. Bonnisan was effective in most of the cases who were suffering from post-antibiotic dyspepsia (100%), non-specific constipation (93.3%), and infantile colics 86.6%.

About 70-75% cases of failure to thrive and vague illness improved remarkably. 60-67% cases of anorexia, vomiting or regurgitation and mild non-specific diarrhoea showed significant improvement.

Teething problem which is a significant cause of anxiety among the parents showed improvement in about 80% of cases.

The response was the same in both the sexes. The acceptance for Bonnisan was excellent in all the cases. No toxic side effect was seen in any of the cases


 Discussion

Weight gain is an index of good growth and development, which depends upon the digestion, utilisation and assimilation of the nutrients provided in the diet. Bonnisan by its digestive qualities helps in better absorption and utilization of the food and by stimulating the various digestive enzymes is believed to promote growth. Bonnisan is also a safe, effective appetite- and growth-promoting agent4.

Hundred and sixteen cases, i.e. 77.3% of the total cases taken up for the study showed significant improvement in the symptoms and weight gain which was above average expected for the particular age-group. In the remaining cases the children did show some improvement but the weight-gain was not above that expected for the age. Our findings are in accordance with some authors6, but others have shown 100% improvement in their cases7,8. The possible explanation for this difference could be that they might have included the cases who had normal weight gain at the time of study.

The success rate seems to be impressive. Bonnisan definitely gives a sense of relief to both patient and the doctor. Here one is faced with an inevitable question - what in the drug has worked? Being an Ayurvedic preparation, no definitive opinion can be given in this respect.


 Conclusion

Upon clinical trial with Bonnisan, we have found satisfactory results particularly in cases having non-specific symptoms like anorexia, weight loss, irritability, regurgitation, and many other gastrointestinal problems. Bonnisan can be prescribed without hesitation for non-specific symptomatology with the caution that when these symptoms occur as a part of a specific gastrointestinal pathology, it might work as an adjunct to the specific therapy for that pathology.


 References
  1. Saxena, S., Liv.52 in anorexia in paediatric practice Curr. med. Pract. (1971): 1, 580.

  2. Dhurandhar, J., Bonnisan - A metabolic corrective in gastrointestinal disorders of the newborn. Probe (1973): 2, 73.

  3. Kulsreshtha, J.K., Lal, G.M. and Laghate, V.D., Bonnisan in newborns and infants—A preliminary study. Probe (1976): 2, 123.

  4. Desai, A.B. et al., Bonnisan - Metabolic tonic of the newborns. Ind. Practit. (1976): 2, 119.

  5. Ansari, I.H., A clinical study on Bonnisan. Probe (1981): 3, 215.

  6. Satyanarayana, M., Murthy, P.S., A study on Bonnisan. Probe (1975): 3, 225.

  7. Indira Bai, K., Subba Rao, V.K., Subramanayam, M.U.G., Bonnisan a digestive corrective and anabolic tonic for newborn infants. Probe (1973): 3, 138.

  8. Sinha, K.P., Bonnisan - A clinical trial. Probe (1975): 1, 20.